$0.77
-0.02 (-2.65%)
Antigenics, Inc. (AGEN)
CAPS Rating:
A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.
A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.